Cowen

Bevi develops a smart water dispenser that provides customizable flavors made from filtered tap water and natural ingredients. Bevi aims to eliminate waste from the production, shipping, and disposing of bottled beverages. Bevi envisions a future where a smarter platform (powered by the municipal water supply) transforms how beverages are delivered.

Hum Capital is the funding platform that connects great companies with the right capital. Hum offers companies raising up to $50 million the most efficient, transparent path to growth. Hum’s Intelligent Capital Market uses AI to translate volumes of a company’s financial data into the clearest picture of their value, so they can fundraise with confidence, on the best terms for their business. Investors on Hum’s platform gain investment insights and a personalized deal flow built on company data they can trust. For more information, visit HumCapital.com.

Digital Prime Technologies is a provider of customizable prime brokerage technology solutions for financial institutions. Its all-in-one user interface leverages both API and SaaS product offerings to connect clients with a growing network of liquidity providers to transact, borrow, and lend digital assets and manage collateral.

AlphaSense is a market intelligence platform that allows professionals to make critical decisions with confidence and speed. The company has nearly 2,000 enterprise clients, including financial institutions that use the platform to inform their business decisions. AlphaSense is trusted by over 1,800 enterprise customers, including a majority of the S&P 500.

Quip is an oral care company designing and delivering products, advice and professional services to make oral health more simple, accessible, and enjoyable — starting with a better electric toothbrush. As the first to market direct-to-consumer oral care subscription service — with fresh supplies delivered every three months, oral care advice sent straight to hundreds of thousands of consumers, and a bidirectional tech platform in development to connect users with a large dental professional network — quip is working to elevate every part of the oral care experience for everyone.

ecoATM acquired Gazelle in 2015, allowing our consumers to have an online or kiosk experience Nationwide. Gazelle ecoATM kiosks are automated machines that make it easy and convenient for people to sell back unwanted tablets and smartphones. Gazelle ecoATM kiosks are located in the malls, grocery stores, and Walmart that people already frequent. People receive cash on the spot for the iPhones and Android devices they no longer use. Gazelle ecoATM kiosks and Gazelle.com provide consumers with real cash, real fast and the best options when it comes to buying and trading in pre-owned electronics. We have a commitment to delivering convenient consumer solutions via online channels or in person, depending on the preference of the consumer. Gazelle ecoATM kiosks and Gazelle.com reward people for smart consumption. Each option provides an easy, safe, fast, and secure way for consumers to trade in their devices for cash at their convenience. Gazelle.com also offers certified pre-owned devices at a better value than competitors.

PolySign develops state-of-the-art, secure, scalable infrastructure for financial institutions to fully leverage their digital assets. The company also develops a secure and scalable infrastructure for financial institutions to fully leverage their digital assets. They aim to integrate with existing financial organizations and global markets, and rigorously embrace the highest standards for regulation.

Omega Therapeutics, Inc. is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines.

Proterra designs and manufactures zero-emission, heavy-duty electric vehicles, enabling bus fleet operators to significantly reduce operating costs while delivering clean, quiet transportation to local communities across North America. The company’s configurable Catalyst platform is designed to serve the daily mileage needs of a wide range of transit routes on a single charge. With industry-leading durability and energy efficiency based on rigorous U.S. independent testing, Proterra products are proudly designed, engineered, and manufactured in America, with offices in Silicon Valley, South Carolina, and Los Angeles. Proterra's revolutionary battery-electric transit vehicles help fleet operators abandon fossil fuels, improve environmental quality, and reduce operating costs. Together with their customers, they have prevented more than 55 million pounds of greenhouse gases from escaping into the atmosphere and avoided burning some 2 million gallons of fuel. The company was established in 2004 and is based in Burlingame, California, USA.

Kyber Data Science LLC is a subsidiary of Cowen Inc. focused on developing and selling unique and proprietary datasets across a variety of sectors to institutional investors and corporations.

ecoATM acquired Gazelle in 2015, allowing our consumers to have an online or kiosk experience Nationwide. Gazelle ecoATM kiosks are automated machines that make it easy and convenient for people to sell back unwanted tablets and smartphones. Gazelle ecoATM kiosks are located in the malls, grocery stores, and Walmart that people already frequent. People receive cash on the spot for the iPhones and Android devices they no longer use. Gazelle ecoATM kiosks and Gazelle.com provide consumers with real cash, real fast and the best options when it comes to buying and trading in pre-owned electronics. We have a commitment to delivering convenient consumer solutions via online channels or in person, depending on the preference of the consumer. Gazelle ecoATM kiosks and Gazelle.com reward people for smart consumption. Each option provides an easy, safe, fast, and secure way for consumers to trade in their devices for cash at their convenience. Gazelle.com also offers certified pre-owned devices at a better value than competitors.

Cowen Group is a financial services firm that provides equity and debt financings, investment banking, and other financial-related services. It also offers mergers and acquisitions, and strategic restructuring advisory services. The firm's sector specializes in healthcare, technology, media and telecommunications, information and technology services, consumer, energy, aerospace and eCommerce, industrials, transportation, and biotechnology industries. Founded in 1918, Cowen also has an investment management division that offers actively managed alternative investment products.

Orchard Therapeutics is a fully integrated commercial-stage company dedicated to treating the lives of patients with rare diseases through innovative gene therapies. Orchard’s portfolio of autologous ex vivo gene therapy programs has demonstrated sustained clinical benefit in over 150 patients across five disease areas. These programs include Strimvelis®, the first autologous ex vivo gene therapy approved by the EMA in 2016, 3 programs in advanced registrational studies in MLD (metachromatic leukodystrophy), WAS (Wiskott-Aldrich syndrome), and ADA-SCID (adenosine deaminase severe combined immunodeficiency), 2 other clinical programs in X-CGD (X-linked chronic granulomatous disease) and beta-thalassemia, as well as an extensive preclinical pipeline. The company is partnered with world-leading institutions in gene therapy, including University College London, Great Ormond Street Hospital, the University of Manchester and Central Manchester University Hospitals, the University of California Los Angeles and Boston Children’s Hospital, and Telethon Institute of Gene Therapy/Ospedale San Raffaele.

Semma Therapeutics, Inc. is focused on developing innovative cell therapies for patients with Type 1 diabetes, who traditionally rely on insulin injections. Founded based on groundbreaking research by Professor Douglas Melton, the company has licensed a method to generate functional, insulin-producing beta cells in the laboratory. Semma Therapeutics aims to combine these proprietary cells with advanced devices to create a comprehensive therapy that can replace the missing beta cells without the need for immunosuppression. By striving to bring this transformative treatment to clinical application, Semma Therapeutics seeks to significantly enhance the lives of diabetes patients. Headquartered in Cambridge, Massachusetts, the company is a subsidiary of Vertex Pharmaceuticals and collaborates strategically with Defymed.

Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders. In parallel with this work, Christopher and Kezar co-founder Jack Taunton, Ph.D. collaborated on several research projects involving protein secretion. This collaboration inspired a belief in the strong synergies between protein degradation and protein secretion, two fertile areas for drug discovery with platform potential.

As a leading technology firm, they provide mission critical software products and technology-enabled services to more than 6,000 clients in 100 markets. Their large and diverse client base of asset managers and financial intermediaries includes investment advisors, hedge funds, mutual funds, plan sponsors, trust banks, family offices, separately managed accounts, broker-dealers, exchanges, alternative trading systems, and investment banks.

CEFC China Energy Company Limited (hereinafter referred to as “CEFC China”) is a private collective enterprise with energy and financial services as its core business. The strategy of the Company seeks to expand international economic cooperation in the energy sector and establish a well-organized international investment bank and an investment group.

G1 Therapeutics, Inc. is a commercial-stage oncology firm focused on the research and marketing of next-generation anticancer treatments.

Livongo is a consumer digital health company that empowers people with chronic conditions to live a better life. It has developed a completely new approach to diabetes management that combines the latest technology with coaching. By offering the right information, tools, and support, at the right time, we provide our members with real-time, personalized insights, and support to make diabetes management easier. Its approach is leading to better financial and clinical outcomes while also creating a better experience for people with diabetes and their care team of family, friends, and medical professionals. It was founded in 2008 and is headquartered in Mountain View, California.

Quarton Partners, headquartered in Birmingham, Michigan, is a premier middle market investment banking firm, serving privately held and publicly traded companies, as well as private equity firms. Quarton Partners assists its clients with mergers and acquisitions, private capital raising, and other financial advisory services. Its principals have successfully completed hundreds of engagements in a wide variety of industries across the U.S. and throughout the world.

BlueCF is one of the leading independent corporate finance companies for mid size transactions in Europe. We advise entrepreneurs, companies and investors on corporate sales and financing topics. Since 2001 BlueCF has advised 180 clients in transactions with a total transaction value of over 4 bn. Euro.

Conifer Securities is a company that was acquired by Cowen Group in 2015

Aquinox Pharmaceuticals Inc., a pharmaceutical company, engages in discovery, development, and commercialization of small molecule therapeutics for the treatment of cancer and inflammatory disease. It offers AQX-MN100, a drug used to treat cancer and inflammatory disease, as well as SH2-containing inositol 5'-phosphatase inhibition program for blood cell recovery. The company was founded in 2004 and is based in Vancouver, Canada.

Maxwell Technologies is in developing, manufacturing and marketing energy storage and power delivery solutions for automotive, heavy transportation, renewable energy, backup power, wireless communications and industrial and consumer electronics applications as well as for radiation-hardened microelectronic components and systems for satellites and spacecraft. Maxwell products are designed and built to provide failure-free performance for the life of the most demanding applications.

Cogent Biosciences uses proprietary T-cell engineering technology in combination with tumor-targeting antibodies to activate the body’s own immune system to fight cancer. Unum’s lead program, based on its antibody-coupled T-cell receptor technology, is expected to enter Phase I clinical testing in the coming months to assess safety and efficacy.

MyoKardia is a clinical-stage biopharmaceutical company that engages in discovering, developing, and commercializing targeted therapies for the treatment of rare cardiovascular diseases. The company's focus is on the treatment of heritable cardiomyopathies and genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. It utilizes its medicine platform to generate an initial pipeline of therapeutic programs for the chronic treatment of the two most common forms of heritable cardiomyopathy-hypertrophic cardiomyopathy and dilated cardiomyopathy. The company was founded in 2012 and is headquartered in Brisbane, California.

Echo Global Logistics is a leading provider of technology-enabled business process outsourcing, serving the transportation and logistics needs of their clients. Their proprietary web-based technology, dedicated service teams and robust procurement power enables their clients to see significant transportation savings while receiving best-in-class service.

Seabridge Gold's resource base of gold, copper and silver is one of the world's largest. Our principal projects are located in Canada. Our objective is to grow resource and reserve ownership per share. Our risk-reducing strategy: acquire North American deposits; expand them through exploration; move them to reserves through engineering; and sell or joint venture them to established producers for mine construction and operation.

Aptose Biosciences is a biopharmaceutical company focused on the discovery, research and development of novel, first-in-class anticancer therapies with high safety profiles. Through its own discovery efforts, as well as partnering activities, Lorus is building a portfolio of promising anticancer drugs ranging from discovery and preclinical to clinical-proof-of concept stage. Lorus seeks suitable partners for subsequent late-stage registration trials and eventual commercialization.

Solar3D is developing a breakthrough 3-dimensional solar cell technology to maximize the conversion of sunlight into electricity. Up to 30% of incident sunlight is currently reflected off the surface of conventional solar cells, and more is lost inside the solar cell materials. Inspired by light management techniques used in fiber optic devices, their innovative solar cell technology utilizes a 3-dimensional design to trap sunlight inside micro-photovoltaic structures where photons bounce around until they are converted into electrons. This next generation solar cell will be dramatically more efficient, resulting in a lower cost per watt that will make solar power affordable for the world.

InterDigital Communications, LLC designs and develops advanced digital wireless technology solutions. The company is based in King Of Prussia, Pennsylvania. InterDigital Communications, LLC operates as a subsidiary of InterDigital, Inc.

Sesen Bio is a late clinical-stage company advancing a broad pipeline of novel anti-cancer agents based on their Targeted Protein Therapeutics (TPTs) platform. Their TPTs genetically combine targeting antibody fragments with cytotoxic protein payloads to create a single fusion protein through Eleven's proprietary one-step manufacturing process.

Blueprint Medicines is driving the development of personalized, highly-selective cancer therapies that harness the growing understanding of the molecular blueprint of cancer. Using its powerful Insights-to-Validation Platform and proprietary chemical library, Blueprint Medicines is working to develop new therapeutic compounds and combination therapies that target the molecular aberrations that cause cancer and the emerging resistance mechanisms that make it increasingly difficult to treat. Founded in 2011 by a proven team of scientists and entrepreneurs with world-renowned expertise in the development of targeted cancer therapies, cancer genomics, and rational drug development, Blueprint Medicines is poised to realize the promise of the cancer data revolution: truly personalized therapies that improve outcomes and shift cancer to a manageable condition.

MyoKardia is a clinical-stage biopharmaceutical company that engages in discovering, developing, and commercializing targeted therapies for the treatment of rare cardiovascular diseases. The company's focus is on the treatment of heritable cardiomyopathies and genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. It utilizes its medicine platform to generate an initial pipeline of therapeutic programs for the chronic treatment of the two most common forms of heritable cardiomyopathy-hypertrophic cardiomyopathy and dilated cardiomyopathy. The company was founded in 2012 and is headquartered in Brisbane, California.

Horizon Therapeutics operates as a biopharmaceutical company. It focuses on the development of prescription drugs for mild to moderate pain relief and arthritis. The company's product candidates include HZT-501, a proprietary fixed-dose combination formulation of NSAID and ibuprofen; and HZT-602, a combination oral drug product consisting of naproxen and famotidine. Horizon Therapeutics is based in Northbrook, Illinois, and was founded in 2005.

GlassesOff is a health care technology company providing consumer-oriented software apps to improve near vision sharpness. The company had developed a non-invasive product helping people suffering from Presbyopia to improve their near vision. It was founded in 2007 and headquartered in Hod Hasharon, HaMerkaz.

Dahlman Rose & Company, LLC is a research-driven investment bank focused on transportation, infrastructure, and industries that compose the global supply chain. The Company provides institutional sales and trading, equity and fixed income research, mergers and acquisitions advisory, and underwriting services. Dahlman Rose is headquartered in New York and has offices in Boston, Houston, and San Francisco.

Cascadian Therapeutics, a clinical-stage biopharmaceutical company, researches and develops, and sells therapeutic products for the treatment of cancer in the United States. The company lead clinical-stage product candidate is tucatinib, an orally active and HER2-selective small molecule tyrosine kinase inhibitor, which is in two Phase Ib trials, one in combination with Kadcyla and another in combination with Xeloda and/or Herceptin. It is also developing Checkpoint kinase 1, a protein kinase that is in pre-clinical studies to regulate the cell division cycle, as well as to DNA damage and replication stress. In addition, the company focuses on the development of novel antibodies and T-cell immunoreceptor with Ig and ITM domains, an inhibitory receptor expressed on T-cells and NK cells that negatively regulate immune response to cancers. It has a license agreement with Array BioPharma Inc. to develop, manufacture and commercialize tucatinib; research collaboration agreement with Sentinel Oncology Ltd. for the discovery of novel Chk1 inhibitors; and collaboration agreement with Adimab LLC for the discovery of novel antibodies against d immunotherapy targets in oncology.

Aurora Flight Sciences designs and builds aerospace vehicles for commercial and military applications. Aurora is headquartered in Manassas, VA, and operates production facilities in Bridgeport, WV, and Columbus, MS as well as a Research and Development Center in Cambridge, MA.

Reef is a provider of internet software applications for the management of e-business.

Nextest Systems Corporation was founded in 1997 and shipped its first product in 1998. Nextest is a low-cost leader in the design and manufacture of ATE for non-volatile memory, microcontrollers, ASIC and System-On-a-Chip (SOC) semiconductors. Nextest's products address the growing demand from manufacturers for testing equipment with increased throughput, reliability, functionality and capacity, while reducing the time to market and cost of test. The company employs approximately 150 employees with sales and support offices worldwide. To date, Nextest has shipped over 1000 systems globally!

D-Pharm (TASE: DPRM) is a drug-development company focused on innovative drugs for the treatment of central nervous system (CNS) conditions. The Company’s particular area of interest is in developing innovative medicine for degenerative and age-related disorders.

SiberCore Technologies Incorporated is a pure-play, Internet IC company developing high-value-added Application Specific Standard Products (ASSPs) for intelligent hardware-based switching and routing platforms, such as Gigabit / Terabit Routers and Layer 2 / 3 / 4 Ethernet Switches. The company's initial products are a family of high-speed high-capacity packet forwarding engines based on Content Addressable Memories (CAM technology) which overcome the performance bottleneck associated with the network's routing table look-up function. This emerging market has been created by the demands of the explosion in datacom traffic, coupled with the worldwide deployment of fiber optics and DWDM. These broadband deployments have shifted the bottleneck from the Access and Transport section of the network, to the Routers and Switches connecting to these pipes. The company's founding technical team gained industry-wide recognition for its world-class design expertise in this area at Nortel Networks. A veteran Executive team in all the functional divisions of the company supplements this preeminent technical team.

TelOptica was funded in 1999 by communications network experts in optical, next-generation network design engineering and in operations research and algorithm development. The TelOptica team today includes highly regarded technologists with experience from established telco giants such as MCI and Sprint, international original equipment manufacturers such as Alcatel / DSC, Nortel, and IBM, and management consulting firms including McKinsey and Associates and Carreker Corporation. TelOptica is a well-funded, fast growing, privately held, optical communications technology company. TelOptica incorporated in Texas , received initial funding and support from the Startech business incubator of Richardson, Texas, and closed on its second round of funding from Trellis Partners, Austin Ventures, Centerpoint Ventures, SSM Ventures of Austin, and SG Cowen in June 2001.

The company provides enterprise portal software for the deployment and management of Intranet and extranet portals. The company's Coreport enterprise portal software allows businesses to provide all their stakeholders with a single, secure point of unified and personalized access to content, applications, processes, and services from any wired or wireless device.

Thoughtworks is a community of passionate individuals whose purpose is to revolutionize software design, creation and delivery. They work with people and organizations who have ambitious missions - whether they are in the commercial, social or government sectors. They set up smart teams who love challenges and think disruptively to help their clients succeed. Their Agile development tools help their clients continuously improve and deliver quality software. They are focused on helping their industry improve, and believe in sharing what they learn. They do this by writing books, blogging, running events, talking at conferences, and championing open source. They are strong believers in the power of software and technology as tools for social change. Through their Social Impact Program, they collaborate with organizations with a humanitarian mission and broad reach, helping them use technology to make an impact. Their mission is to better humanity through software and help drive the creation of a socially and economically just world. They bring together the most capable, driven and passionate people - they call them ‘ThoughtWorkers Wherever they are in the world, ThoughtWorkers share the same cultural characteristics and imperatives. They come to work as theirselves. They enjoy each other’s company. They value honesty and transparency. Appearances and backgrounds aren’t important to us; ideas and doing the right thing are. They abhor and reject discrimination and inequality and promote diversity in all its forms. They proudly, passionately and actively strive to make both ThoughtWorks and their industry more reflective and inclusive of the society that they serve.

With more than 15 million page-views and more than 700,000 unique users per month, IPO.COM is the leading Internet provider of content and services to investors interested in initial public offerings, private placements and emerging growth companies. The company provides comprehensive IPO content including offering summaries, up-to-date pricing and filings, searchable EDGAR documents, daily columns and free weekly e-mail newsletters through the company's interactive portal and more than 150 financial web sites. Privately held, IPO.COM has offices in New York, Pennsylvania and California.

Tripod provides the tools to allow users to develop fully functional websites online with professional-looking templates and plugins. Tripod offers value-added services to let users take advantage of Search Engine Optimization professionals, Theme development by professional web designers as well as plugin development and site migration service by seasoned engineers.